NEW YORK (GenomeWeb News) — Third Wave Technologies today said third-quarter revenues increases 26 percent as net loss declined 30 percent.
 
Total receipts for the three months ended Sept. 30 increased to $6.6 million from $5.2 million year over year. Molecular diagnosis contributed $5.2 million.
 
R&D expenses on the quarter were up sharply, at $3.5 million compared with $2 million the previous year.
 

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

At his FDA Law Blog, Jeffrey Gibbs discusses FDA's technical assistance for the draft Diagnostic Accuracy and Innovation Act.

The New York Times reports that genetic testing has uncovered unfaithful penguins at a Utah aquarium.

Cancer researcher loses funding under new Wellcome Trust anti-bullying policies, the Guardian reports.

In Science this week: International Wheat Genome Sequencing Consortium publishes the bread wheat cultivar Chinese Spring reference genome, and more.